Tumor Grade and Molecular Characteristics Associated with Survival in Sporadic Medullary Thyroid Carcinoma.

The International Medullary Thyroid Carcinoma Grading System (IMTCGS) divides medullary thyroid carcinoma (MTC) into two categories, high- and low-grade tumors, which has a profound impact on patient outcomes. The aim of this study was to explore the association between IMTCGS grading, clinical data, and molecular status in sporadic MTC. A retrospective cohort study was performed on consecutive sporadic MTCs from patients undergoing initial surgery between January 2000 and January 2022 at the Padua Endocrine Surgery Unit. Clinical, pathological, and follow-up data were collected, tumors were graded, and somatic mutations of and genes were analyzed. Patient outcomes were based on Ct levels and MTC-related deaths. Survival analyses were carried out employing the Kaplan-Meier method and the log-rank test. A Cox proportional hazard regression model was employed for multivariable survival analysis with the following covariates: somatic mutation, MTC stage at diagnosis, sex, age at diagnosis, and IMTCGS grade. We included 141 consecutive sporadic MTCs. The median follow-up was 80.0 months (interquartile ranges: 41.5-122.5 months). Seventeen patients (12.1%) died from disease-related causes. 107/141 (76.9%) were classified as low-grade tumors, 32/141 (23.1%) as high-grade. Patients carrying a mutation had more aggressive features and shorter disease-specific survival (DSS) ( = 0.001) and were more frequently classified high-grade than low-grade MTC ( < 0.001). At multivariable survival analysis, only IMTCGS grading was independently associated with DSS (hazard ratio 8.8 [confidence interval: 2.7-28.3],  = 0.005). mutations, in particular -M918T, were more frequent in high-grade than in low-grade MTC (68.8% vs. 29.4% mutated in , 46.9% vs. 12.7% mutated in -M918T;  < 0.001). None of the high-grade tumors was mutated in the gene, but the mutation was present in 11.8% of low-grade tumors. IMTCGS grading was associated with DSS independently of other clinical, pathological, and molecular factors. Moreover, MTC grading was associated with and patterns, which explains, at least in part, the molecular basis of the aggressive behavior of high-grade MTC.